Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.8751
-0.0349 (-3.84%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $7.13 million as of April 13, 2026. Its market cap has increased by 13.87% in one year.
Market Cap
7.13M
Enterprise Value
7.12M
1-Year Change
13.87%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $7.13M, a decrease of -98.29%. That is a compound annual growth rate of -42.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 7.41M | -14.15% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 7.91M |
| Quince Therapeutics | 7.59M |
| TransCode Therapeutics | 7.53M |
| Acurx Pharmaceuticals | 7.45M |
| BioAtla | 7.39M |
| Processa Pharmaceuticals | 7.37M |
| MetaVia | 7.18M |
| Silo Pharma | 7.17M |